Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Euro Broadcast News.
Press releases published on May 13, 2025
Stefna dulritunarmilljónamæringa: Frá $100 til $1 milljón á 30 dögum með ZA Miner skýjanámuvinnslu
GlobeNewswire
·
May 13, 2025
London, UK, May 13, 2025 (GLOBE NEWSWIRE) -- Dulritunargjaldmiðlar hafa skapað nýja kynslóð milljónamæringa og breytt litlum fjárfestingum í augnabliksauð . En hvað knýr slíkar velgengnissögur, tímasetningu, auðæfi, stefnumótun eða aðeins meira? Frá …
Trackinsight veröffentlicht Global ETF Survey 2025: ETF-Branche im Hochbetrieb – Neue Gänge, neue Grenzen
GlobeNewswire
·
May 13, 2025
Paris, 13. Mai 2025 – Trackinsight, ein weltweit führendes Unternehmen im Bereich ETF-Analyse und -Forschung, kündigt gemeinsam mit J.P. Morgan Asset Management und S…
Trackinsight Releases 2025 Global ETF Survey: ETF Industry on Overdrive: Shifting Gears, Breaking New Barriers
GlobeNewswire
·
May 13, 2025
Trackinsight, in partnership with J.P. Morgan Asset Management and S…
Trackinsight publie son enquête mondiale sur les ETF 2025 : ETF Industry on Overdrive: Shifting Gears, Breaking New Barriers
GlobeNewswire
·
May 13, 2025
Paris, le 13 mai 2025 – Trackinsight, leader mondial de l’analyse et de la recherche sur les ETF, annonce aujourd’hui, en partenariat avec J.P. Morgan Asset Management et S…
EnteroBiotix Presents Positive Data in Liver Cirrhosis at EASL 2025
GlobeNewswire
·
May 13, 2025
EnteroBiotix Presents Positive Data in Liver Cirrhosis at EASL 2025 EBX-102 was well tolerated and showed multiple positive trends over placebo Findings support progression to a Phase 2b trial Glasgow, Scotland – 13 May 2025. EnteroBiotix Limited (‘ …
Recipharm and PLG announce strategic partnership to accelerate development projects
GlobeNewswire
·
May 13, 2025
Combines Recipharm’s development and manufacturing capabilities with PLG’s product development expertise and regulatory affairs experience Reduces timelines to first-in-human clinical trials and market approvals, through the combined expertise of two …
TILT Biotherapeutics Announces Closing of USD 25 Million Series B Financing
GlobeNewswire
·
May 13, 2025
HELSINKI, May 13, 2025 (GLOBE NEWSWIRE) -- TILT Biotherapeutics (Tiltbio), a clinical-stage biotechnology company developing intravenously delivered cancer immunotherapies, announces it has raised USD 25.6 million (EUR 22.6 million) in a Series B financing …
Eleva Appoints Donato Spota as Chief Financial Officer
GlobeNewswire
·
May 13, 2025
Freiburg im Breisgau, Germany, May 13, 2025 – Eleva, a pioneer in discovering and developing previously inaccessible biologics based on a breakthrough technology platform, appointed Mr. Donato Spota as Chief Financial Officer (CFO) and Managing Director. …
First patients dosed in final cohort of Phase 1b clinical trial of HER-096 for Parkinson’s disease
GlobeNewswire
·
May 13, 2025
Herantis Pharma Plc – Press release First patients dosed in final cohort of Phase 1b clinical trial of HER-096 for Parkinson’s disease HER-096 is a first-in-class agent in development for the treatment of Parkinson’s disease with disease modifying …
Quadient and Nuvei Sign New Partnership to Enhance Cloud Payment Capabilities for Businesses Globally
GlobeNewswire
·
May 13, 2025
The partnership supports seamless, secure payments through Quadient’s AR and AP solutions for businesses across North America, the UK and Europe Quadient (Euronext Paris: QDT), a global automation platform powering secure and sustainable business …
Quadient et Nuvei signent un nouveau partenariat pour renforcer les capacités de paiement dans le cloud à l’échelle mondiale
GlobeNewswire
·
May 13, 2025
Ce partenariat garantit des paiements fluides et sécurisés via les solutions comptes clients et fournisseurs de Quadient en Amérique du Nord, au Royaume-Uni et en Europe Quadient (Euronext Paris : QDT), une plateforme mondiale d'automatisation facilitant …
Progress on share buyback programme
GlobeNewswire
·
May 13, 2025
Progress on share buyback programme ING announced today that, as part of our €2.0 billion share buyback programme announced on 2 May 2025, in total 6,750,294 shares were repurchased during the week of 5 May 2025 up to and including 9 May 2025. The shares …
2024 Exploration Update for Strategic Minerals JV
GlobeNewswire
·
May 13, 2025
Reykjavík, May 13, 2025 (GLOBE NEWSWIRE) -- (“Amaroq” or the “Company” or the “Corporation”) 2024 Exploration Update for Strategic Minerals JV Amaroq Advances its Strategic Minerals Vision — Welcoming Dr. Steve Garwin TORONTO, ONTARIO – May 13, 2025 – …
CopenPay returns 3 times bigger: Copenhagen now rewards tourists who arrive by train
GlobeNewswire
·
May 13, 2025
Copenhagen, May 13, 2025 (GLOBE NEWSWIRE) -- Copenhagen’s green experience economy, CopenPay, is back. The goal is to raise tourists’ awareness about making more sustainable choices. This year, the initiative, which allows visitors to “pay” for experiences …
CopenPay returns 3 times bigger: Copenhagen now rewards tourists who arrive by train
GlobeNewswire
·
May 13, 2025
COPENHAGEN, Denmark, May 13, 2025 (GLOBE NEWSWIRE) -- Copenhagen’s green experience economy, CopenPay, is back. The goal is to raise tourists’ awareness about making more sustainable choices. This year, the initiative, which allows visitors to “pay” for …
EG 427 highlights at ASGCT major advances made with its HERMES platform in neurology using versatile non-replicative herpes vectors
GlobeNewswire
·
May 13, 2025
Data highlights advantages of single, non-replicative HSV-1 (nrHSV-1) vector hosting two transgenes with independent expression kinetics Vectors also show high transduction rate of neurons in the CNS at very low doses and can be efficiently distributed to …
EG 427 présente à l’ASGCT des avancées majeures réalisées avec sa plateforme HERMES en neurologie, démontrant la polyvalence de ses vecteurs herpétiques non-réplicatifs
GlobeNewswire
·
May 13, 2025
Les données montrent les avantages d'un vecteur HSV-1 non réplicatif (nrHSV-1) unique intégrant deux transgènes présentant des cinétiques d'expression indépendantes. Ces vecteurs transduisent efficacement les neurones du SNC à de très faibles doses et …
Galapagos Announces Strategic Update on Proposed Separation, Executive Leadership Transition and Board Changes
GlobeNewswire
·
May 13, 2025
Galapagos to re-evaluate the implementation of the previously announced separation following regulatory and market developments Galapagos to explore all strategic alternatives for its existing businesses, including cell therapy, with a focus on maximizing …
Galapagos kondigt een strategische update aan over de geplande splitsing, de transitie van het uitvoerend leiderschap, en wijzigingen in de Raad van Bestuur
GlobeNewswire
·
May 13, 2025
Galapagos heroverweegt uitvoering van eerder aangekondigde splitsing naar aanleiding van ontwikkelingen in regelgeving en de markt Galapagos onderzoekt alle strategische alternatieven voor haar bestaande activiteiten, waaronder celtherapie, met de nadruk …
Jeito Capital leads EUR 132 million oversubscribed Series B financing in Azafaros to advance Phase 3 clinical programs of innovative therapies in rare inherited neuro-metabolic disorders
GlobeNewswire
·
May 13, 2025
Jeito Capital leads EUR 132 million oversubscribed Series B financing in Azafaros to advance Phase 3 clinical programs of innovative therapies in rare inherited neuro-metabolic disorders Proceeds will support two Phase 3 pivotal programs with nizubaglustat …